Guozuo Wang

448 total citations
10 papers, 315 citations indexed

About

Guozuo Wang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Neurology. According to data from OpenAlex, Guozuo Wang has authored 10 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 3 papers in Pulmonary and Respiratory Medicine and 3 papers in Neurology. Recurrent topics in Guozuo Wang's work include Neurological Disease Mechanisms and Treatments (3 papers), Mitochondrial Function and Pathology (3 papers) and Cancer-related molecular mechanisms research (3 papers). Guozuo Wang is often cited by papers focused on Neurological Disease Mechanisms and Treatments (3 papers), Mitochondrial Function and Pathology (3 papers) and Cancer-related molecular mechanisms research (3 papers). Guozuo Wang collaborates with scholars based in China and Canada. Guozuo Wang's co-authors include Jinwen Ge, Jun Liao, Zhigang Mei, Danhong Liu, Bin Lan, Xi‐Long Zheng, Chao He, Shaowu Cheng, Jun Liao and Anqi Ge and has published in prestigious journals such as Frontiers in Immunology, Biochemical Pharmacology and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Guozuo Wang

10 papers receiving 312 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guozuo Wang China 6 158 128 125 82 36 10 315
Le Shao China 9 200 1.3× 79 0.6× 50 0.4× 82 1.0× 37 1.0× 14 316
Maoxing Fei China 9 203 1.3× 93 0.7× 108 0.9× 34 0.4× 45 1.3× 15 359
Yueran Cui China 8 199 1.3× 95 0.7× 48 0.4× 67 0.8× 26 0.7× 10 311
Fari Ryan Canada 10 176 1.1× 95 0.7× 127 1.0× 56 0.7× 28 0.8× 15 340
Shao-Xin Gong China 7 124 0.8× 59 0.5× 62 0.5× 113 1.4× 49 1.4× 13 333
Shanyu Ye China 8 285 1.8× 149 1.2× 80 0.6× 22 0.3× 19 0.5× 10 363
Yaqian Xu China 10 200 1.3× 177 1.4× 106 0.8× 22 0.3× 23 0.6× 31 344
Yongfei Dong China 10 188 1.2× 122 1.0× 25 0.2× 64 0.8× 35 1.0× 24 325
Shengmei Zhu China 11 190 1.2× 149 1.2× 21 0.2× 67 0.8× 30 0.8× 20 361

Countries citing papers authored by Guozuo Wang

Since Specialization
Citations

This map shows the geographic impact of Guozuo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guozuo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guozuo Wang more than expected).

Fields of papers citing papers by Guozuo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guozuo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guozuo Wang. The network helps show where Guozuo Wang may publish in the future.

Co-authorship network of co-authors of Guozuo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Guozuo Wang. A scholar is included among the top collaborators of Guozuo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guozuo Wang. Guozuo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Liu, Yaxin, Jung Hwa Hong, Guozuo Wang, & Zhigang Mei. (2025). An emerging role of SNAREs in ischemic stroke: From pre-to post-diseases. Biochemical Pharmacology. 236. 116907–116907. 1 indexed citations
2.
Xu, Ruiyi, et al.. (2025). ncRNAs-Mediated Pyroptosis in Cerebral Ischemia-Reperfusion Injury: Pathophysiology, Mechanisms, and Therapeutic Perspectives. Current Issues in Molecular Biology. 47(3). 141–141. 1 indexed citations
3.
Zhou, Jing, et al.. (2024). No-reflow after recanalization in ischemic stroke: From pathomechanisms to therapeutic strategies. Journal of Cerebral Blood Flow & Metabolism. 44(6). 857–880. 15 indexed citations
4.
Liu, Danhong, et al.. (2023). Mitochondrial dysfunctions induce PANoptosis and ferroptosis in cerebral ischemia/reperfusion injury: from pathology to therapeutic potential. Frontiers in Cellular Neuroscience. 17. 1191629–1191629. 88 indexed citations
5.
Yang, Kailin, Liuting Zeng, Anqi Ge, et al.. (2022). A systematic review of the research progress of non-coding RNA in neuroinflammation and immune regulation in cerebral infarction/ischemia-reperfusion injury. Frontiers in Immunology. 13. 930171–930171. 76 indexed citations
6.
Wang, Guozuo, Xiaomei Zeng, Kailin Yang, et al.. (2022). Uncovering the Neuroprotective Effect of Hedysarum multijugum Maxim-Chuanxiong Rhizoma Compound on Cerebral Infarction through Quantitative Proteomics. Evidence-based Complementary and Alternative Medicine. 2022. 1–13. 2 indexed citations
7.
Wang, Guozuo, Xiaomei Zeng, Shanshan Wang, et al.. (2022). Exploring the Mechanism of Edaravone for Oxidative Stress in Rats with Cerebral Infarction Based on Quantitative Proteomics Technology. Evidence-based Complementary and Alternative Medicine. 2022. 1–21. 3 indexed citations
8.
Lan, Bin, Jinwen Ge, Shaowu Cheng, et al.. (2020). Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats. Journal of Integrative Medicine. 18(4). 344–350. 106 indexed citations
9.
Liao, Jun, et al.. (2015). Naotaifang extract treatment results in increased ferroportin expression in the hippocampus of rats subjected to cerebral ischemia. Molecular Medicine Reports. 11(6). 4047–4052. 17 indexed citations
10.
Chen, Yi, et al.. (2014). [Regulation of naotai recipe on the expression of HIF-lα/VEGF signaling pathway in cerebral ischemia/reperfusion rats].. PubMed. 34(10). 1225–30. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026